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Abstract—Dynamic contrast enhanced ultrasound (DCE-US)
imaging has the potential to provide quantitative information
which is sensitive to tumour perfusion, an indicator for tumour
response to radiotherapy. To increase the reproducibility of time-
intensity curve (TIC) characteristics, we are developing a 3D
DCE-US imaging system. There are, however, many choices to be
made in system design, such as whether to use plane wave (PWI)
or focused imaging (FI), and the values to use for parameters
such as focal depth (FD), F-number (F#), mechanical index (MI)
and number of angles (NA) (for PWI). We evaluated the effect of
such choices on TICs (we refer to time-amplitude curve (TAC)
here), using a microvascular flow phantom containing ∼100,000
parallel microtubes, each 200 µm in diameter. DCE-US 2D images
were obtained using a Vantage (Verasonics Inc.) and a pulse-
inversion algorithm. 800 frames were recorded at 10 Hz for PWI
and FI. All measurements were repeated 3 times, injecting 0.4
ml of contrast agent (Sonozoid) and changing one parameter at
a time, using the values: FD = 20, 40 mm; F# = 2, 4; MI =
0.11, 0.15, 0.25; NA = 3, 7, 11. For a large region of interest
which included the periphery of the phantom, TACs were sharp
and single-peaked for F2 but broader and double-peaked for F4,
consistent with F4 averaging over a greater focal volume than
F2. Choosing a smaller more central ROI reduced the effect but
did not eliminate it completely. Placing the focus deeper than the
center reduced the TAC amplitude due to attenuation but also
resulted in a flatter TAC. PWI amplitude was greatest for 3 angles
with evidence that this may be due to side lobe artefacts added to
the contrast signal. TAC characteristics are thus expected to be
highly sensitive to imaging parameters. This should be considered
in longitudinal studies.
Index Terms—Dynamic contrast enhanced ultrasound imaging,
time intensity curve (TIC), time amplitude curve (TAC), imaging
mode, parameter setting, microvascular phantom.
I. INTRODUCTION
Chemoradiation can significantly affect tumour blood perfu-
sion soon after treatment, which can be used as an indicator to
differentiate between responders and non-responders [1], [2].
On the other hand, standard evaluation of tumour response
based on the tumour size usually needs one to two months of
treatment before it shows any meaningful changes. Therefore,
an accurate and reproducible technique to assess changes in
aspects of tumour function, such as vascularity, at early time
points, i.e. within one to two weeks, may be vital as a potential
way to improve how we treat patients [3]. Dynamic contrast
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enhanced ultrasound (DCE-US) imaging provides perfusion
information [4] and has been recognized as a useful tool
to assess tumour response. This is based on the change in
contrast signal of the region of interest (ROI), known as a
time-intensity curve (TIC), when microbubbles pass through
the region [5]. Changes in TIC characteristics such as wash-
in time, wash-out time and peak intensity have been related
to the function of tumour vasculature and thus its response
to chemoradiotherapy [1], [2]. To make a reliable assessment
of these characteristics specially in longitudinal studies, an
accurate, precise and reproducible quantification technique
is needed, ideally irrespective of the ultrasound equipment,
imaging mode, system parameters and subject variables. Con-
sidering this, we are developing a 3D DCE-US imaging
system, which is expected to increase reproducibility of the
measured contrast ultrasound characteristics between imaging
sessions compared to 2D, thereby improving sensitivity to
therapy-induced changes in the vasculature [6]–[11]. There
are, however, many choices to be made in system design,
such as whether to use plane wave imaging (PWI) or focused
imaging (FI), and the values to use for parameters such as
focal depth (FD), F-number (F#), mechanical index (MI) and
number of angles (NA) (for PWI). Most of the previous studies
on TIC evaluation have focused on scanner parameters such as
dynamic range and gain, compression, TIC fitting or region of
interest (ROI) selection [12]–[15]. Some groups have studied
contrast enhanced ultrasound imaging (CEUS) variability with
respect to one or two system parameters including pulse
length, frequency, MI and imaging modes [16]–[18], without
further evaluation of the corresponding TICs. Here we evaluate
the effect of such choices on TICs for a microvascular flow
phantom in vitro. Since contrast echo amplitude images were
analysed in the present work, from hereon we refer to time-
amplitude curves (TACs) rather than TICs.
II. MATERIALS AND METHODS
A dialysis cartridge was used as the microvasculature
phantom, containing ∼100,000 parallel microtubes, each 200
µm in diameter. It was connected to a peristaltic pump (HR
flow inducer type MHRE 200-250v, Watson Marlowe Ltd,
Falmouth, UK) as shown in fig. 1. Maintaining a constant flow
of degassed water through the system, 0.4 ml of contrast agent
(SonozoidTM; GE Healthcare, Oslo, Norway) was injected at
3.18 ml/min as a bolus injection using a NE-1010 injection
pump (New Era Pump Systems Inc., NY, USA). DCE-US
images were obtained using a VantageTM system (Verasonics
Inc., Kirkland WA, USA) and reconstructed using a two-
pulse pulse-inversion algorithm with 150 µs pulse intervals to
generate a microbubble-specific echo signal [19]. To evaluate
the TACs, 850 frames were acquired for both FI and PWI,
corresponding to 85 seconds of TAC starting from injection,
which spanned the full wash-in and a part of wash-out period.
For each selected ROI, TAC was calculated as the mean signal
amplitude of the ROI pixels. 128 focused beamlines were
acquired for FI with 300 µs (= 2 × pulse interval) line intervals
and 10 Hz image frame rate. For PWI, frame rate was also
adjusted to 10 Hz with the compounding angle intervals of
300 µs. Various number of compounding angles were used
for PWI tilted from -10 to +10 degrees. Default parameters
were selected so that FI and PWI had similar contrast and
microbubble disruption rate in a simple single-vessel flow
phantom. The parameters were: FD = 20 mm (for FI), F# = 4,
MI = 0.15, transmit frequency = 4 MHz, NA = 7 (for PWI).
To evaluate the TAC for each parameter independent of the
others, measurements were repeated changing one parameter
at a time, using the values: FD = 20 mm, 40 mm; F# = 2, 4;
MI = 0.11, 0.15, 0.25; NA = 3, 7, 11. All measurements were
repeated 3 times. TACs were then evaluated for FI and PWI
for different ROIs.
Fig. 1: Phantom setup composed of a dialysis cartridge con-
nected to a peristaltic pump and an injection pump to inject
the contrast agent through the system. (The mixed fluid of
water and contrast agent was removed from the system after
passing through the cartridge.)
III. RESULTS
Fig. 2a shows the FI Bmode (left) and contrast mode (right)
images of the phantom in absence of the contrast agent. The
phantom provided reproducible TACs that were tumour-like
in being dependent on distance from the center. Blue, red
and green ROIs correspond to a big ROI (ROI-big), a small
central one (ROI-center) and a peripheral one (ROI-periphery),
respectively. Fig. 2b and 2c show TACs for FI and PWI for
different ROIs in matching colours. For both FI and PWI,
TACs had 2 peaks for all ROIs and the peripheral ROI (in
green) gave a slower wash-in compared to the central ROI
TAC (in red). PWI had a smoother TACs with less distinct
peaks compared to the FI TACs. Also, the peak amplitudes
were greater for FI.
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Fig. 2: (a) Bmode (left) and contrast mode (right) of the
phantom. Blue, red and green ROIs correspond to ROI-big,
ROI-center and ROI-periphery in (b) and (c), (b) FI TACs for
different ROIs and (c) PWI TACs for different ROIs.
Fig. 3 shows FI TACs for different F#s and FDs using
ROI-big (fig. 3a) and ROI-center (fig. 3b). They show that
for ROI-big, TACs were sharp and single-peaked for F2 but
broader and double-peaked for F4 (fig. 3a). Choosing a smaller
ROI reduced the second peak for F4 but did not eliminate it
completely (fig. 3b). Placing the focus deeper than the center
reduced the TAC amplitude (green) for both ROIs due to
attenuation but also resulted in less region dependence and
a flatter TAC.
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Fig. 3: FI TACs for different F#s and FDs using (a) ROI-big
and (b) ROI-center.
PWI TAC amplitude was greatest for 3 angles (fig. 4) and
reduced with increasing numbers of angles. Higher MIs gave
greater TAC amplitudes for both PWI and FI as expected.
Unlike 0.1 and 0.15 MI where FI and PWI had similar TAC
amplitudes, at 0.25 MI, FI had greater amplitude compared to
PWI (fig. 5).
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Fig. 4: PWI TACs for different number of compounding
angles.
IV. DISCUSSION
The two-peaked appearance of the TACs were likely caused
by the combination of two distinct wash-in phases, one faster
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Fig. 5: FI and PWI TACs for different MIs.
than the other (fig. 2b and 2c). The phantom had a spatially
heterogeneous wash-in pattern; the contrast agent arrived at
the center first and then at the periphery. Therefore a faster
wash-in in the central ROI compared to the peripheral ROI
was expected, see fig. 2b. The largest ROI, ROI-big, which
contained both periphery and central areas, may have a com-
bined pattern of these two ROIs, and so there was no dominant
peak in the blue curves (see fig. 2b and 2c).
The main difference between FI and PWI TACs was that
PWI gave smoother TACs. This was probably caused by three
different phenomena. 1) PWI has a wider lateral beam width
which in combination with forward scattering (rescattering) of
the contrast echo signal, can result in depth confusion in the
TACs. This means that each ROI may contain information that
is a combination of signal from its own pixels and forward
scattered signal from the shallower (anterior) region of the
phantom. The impact of forward scattering mostly depends
on the shape and the width of the beam around and anterior
to the ROI. 2) Target (microbubbles) movement between the
compunding angles, can lead to failure of synthetic focusing
for PWI and as a result a wider point spread function (PSF)
and a greater sidelobes, which can lead to a combination of
information from different areas and a smoother TAC. 3) It
may be partially due to high frequency grating lobe artefacts
which we observed in a separate study where PWI and FI
were evaluated over a single vessel flow phantom (not shown
here) and PWI was seen to suffer from grating lobe artefacts
that originated from high frequency component of the contrast
signal (not seen for FI). Grating lobes usually have a greater
footprint than the mainlobe and can mix the information from
different areas and depths which in this case, probably led to
a smoother TAC with less distinct peaks for PWI.
For ROI-big, TACs were sharp and single-peaked for F2 but
broader and double-peaked for F4 (fig. 3a). Choosing a smaller
more central ROI, reduced the second peak amplitude for F4
but did not eliminate it completely (fig. 3b). It is likely that
because F4 provides a weaker focus, it may be more influenced
by the forward scattering coming from anterior pixels. As
mentioned above, the effect of forward scattering and depth
confusion depends on the shape and width of the beam around
and anterior to a particular pixel. It was also observed that TAC
for F2 was only localized around the focal region and moving
the ROI away from the focal depth towards the periphery,
TAC for F2 was broader compared to F4 (not shown here).
This is probably because F2 has a wider lateral beam width
out of the focal region compared to F4 which can increase
the forward scattering effect for F2. It should be noted that
as the microtubes were not wall-less, the scattering nature of
them may add to the forward scattering effect compared to an
in-vivo situation which should be examined in future works.
Tumours are usually similar to this phantom in terms of
heterogeneity [20], however, the contrast agents tend to wash
in to the periphery of the tumour first, the reverse to our
phantom. Therefore, the same problems are expected to be
seen in-vivo. For a small ROI at the focal region or a small
tumour in general (<10 mm diameter), FI with a tight focus
(small F#) seems to be the best choice to provide a localized
TAC, however, for larger tumours, if out of focus regions are
also being considered, small F#’s gives a broad and smoothed
TAC for that regions. For larger tumours with multiple in
and out of focus ROIs or a big ROI in general, it might be
better to use larger F# which provides more homogeneous
TACs, although this will be a combination of the ROI pixels
signal and the forward scattered signal from anterior pixels.
This also happens for PWI to a much greater extent. Multi-
focal FI with low F#’s may solve the problem at the expense
of temporal resolution which may present a problem for 3D
imaging. So, there are trade-offs in choosing the best setting
and the decision should be made based on the application.
PWI TAC amplitude was greatest for 3 angles (fig. 4). This
may be due to side lobe and high frequency artefacts added
to the contrast signal, which were observed in the image (data
not shown).
TAC for different MI’s showed that, unlike 0.1 and 0.15
MI where FI and PWI gave similar TAC amplitudes, at 0.25
MI, FI has a greater amplitude compared to PWI (fig. 5).
A likely cause is that at higher MIs, microbubble disruption
rate increases which then can lead to incoherent summation
between the PWI compounding angles and reduce the PWI
amplitude. On the other hand, the higher desruption rate
between the PI positive and negative pulses can lead to a
false contrast increase for FI and PWI. The combination of
the two phenomena would result in a greater amplitude for FI
compared to PWI at higher MIs.
V. CONCLUSION
This study showed that TAC characteristics are highly
sensitive to imaging parameters and this should be considered
in longitudinal studies. Also, the parameter setting should
be carefully selected base on the tumour and ROI size. FI
with smaller F# is a good option for small tumours/ROIs,
however, this study suggest that bigger F#’s give a more
homogeneous TAC’s in larger tumours/ROIs. PWI imaging
suffered a greater amount of depth confusion in this study and
provided a smoothed TAC. Evaluating different pulse shapes
or aperture sizes to reduce these effects is a topic for future
work.
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